Kirkwood JM - Search Results

1

CD56^dim CD16^- Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α.

Vujanovic L, Chuckran C, Lin Y, Ding F, Sander CA, Santos PM, Lohr J, Mashadi-Hossein A, Warren S, White A, Huang A, Kirkwood JM, Butterfield LH. Vujanovic L, et al. Among authors: kirkwood jm. Front Immunol. 2019 Jan 29;10:14. doi: 10.3389/fimmu.2019.00014. eCollection 2019. Front Immunol. 2019. PMID: 30761123 Free PMC article.

2

Depressed ability of patients with melanoma or renal cell carcinoma to generate adherent lymphokine-activated killer cells.

Sedlmayr P, Rabinowich H, Elder EM, Ernstoff MS, Kirkwood JM, Herberman RB, Whiteside TL. Sedlmayr P, et al. Among authors: kirkwood jm. J Immunother (1991). 1991 Oct;10(5):336-46. doi: 10.1097/00002371-199110000-00005. J Immunother (1991). 1991. PMID: 1790141

3

Effects of interferon-gamma and tumour necrosis factor-alpha on the development of cytotoxic T lymphocytes in autologous mixed lymphocyte tumour cultures with human melanoma.

Roth AD, Hornicek FJ, Gerstner CG, Kirkwood JM. Roth AD, et al. Among authors: kirkwood jm. Clin Exp Immunol. 1991 Oct;86(1):163-72. doi: 10.1111/j.1365-2249.1991.tb05790.x. Clin Exp Immunol. 1991. PMID: 1833098 Free PMC article.

4

Estrogen receptor concentration and social factors as predictors of natural killer cell activity in early-stage breast cancer patients. Confirmation of a model.

Levy SM, Herberman RB, Lee J, Whiteside T, Kirkwood J, McFeeley S. Levy SM, et al. Nat Immun Cell Growth Regul. 1990;9(5):313-24. Nat Immun Cell Growth Regul. 1990. PMID: 2077396

5

The role of interferons in the therapy of melanoma.

Kirkwood JM. Kirkwood JM. Immunol Ser. 1994;61:239-50. Immunol Ser. 1994. PMID: 7516716 Review. No abstract available.

6

Systemic therapy of melanoma.

Kirkwood JM. Kirkwood JM. Curr Opin Oncol. 1994 Mar;6(2):204-11. doi: 10.1097/00001622-199403000-00014. Curr Opin Oncol. 1994. PMID: 8011698 Review.

7

Phase IB trial of picibanil (OK-432) as an immunomodulator in patients with resected high-risk melanoma.

Kirkwood JM, Wilson J, Whiteside TL, Donnelly S, Herberman RB. Kirkwood JM, et al. Cancer Immunol Immunother. 1997 May;44(3):137-49. doi: 10.1007/s002620050366. Cancer Immunol Immunother. 1997. PMID: 9191873 Free PMC article. Clinical Trial.

8

Adjuvant therapy of melanoma.

Agarwala SS, Kirkwood JM. Agarwala SS, et al. Among authors: kirkwood jm. Semin Surg Oncol. 1998 Jun;14(4):302-10. doi: 10.1002/(sici)1098-2388(199806)14:4<302::aid-ssu6>3.0.co;2-6. Semin Surg Oncol. 1998. PMID: 9588723 Review.

9

Adjuvant interferon treatment for melanoma.

Agarwala SS, Kirkwood JM. Agarwala SS, et al. Among authors: kirkwood jm. Hematol Oncol Clin North Am. 1998 Aug;12(4):823-33. doi: 10.1016/s0889-8588(05)70025-3. Hematol Oncol Clin North Am. 1998. PMID: 9759581 Review.

10

Inflammatory cell infiltrate in a responding metastatic nodule after vaccine-based immunotherapy.

Logan TF, Banner B, Rao U, Ernstoff MS, Wolmark N, Whiteside TL, Miketic L, Kirkwood JM. Logan TF, et al. Among authors: kirkwood jm. Clin Exp Immunol. 1998 Dec;114(3):347-54. doi: 10.1046/j.1365-2249.1998.00731.x. Clin Exp Immunol. 1998. PMID: 9844042 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

609 results

Search Page

Filters